Wells Fargo Remains a Buy on Elevance Health (ELV)
Wells Fargo analyst Stephen Baxter reiterated a Buy rating on Elevance Health (ELV – Research Report) yesterday and set a price target of ...
Elevance Health upgraded to Buy from Hold at Argus
Argus upgraded Elevance Health (ELV) to Buy from Hold with a $450 price target Light Up your Portfolio with Spark:Easily identify stocks' risks ...